The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?

The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy. The FDA warning was grounded on industry-sponsored trials carried one decade ago...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornaro, Michele, Anastasia, Annalisa, Valchera, Alessandro, Carano, Alessandro, Orsolini, Laura, Vellante, Federica, Rapini, Gabriella, Olivieri, Luigi, Di Natale, Serena, Perna, Giampaolo, Martinotti, Giovanni, Di Giannantonio, Massimo, De Berardis, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510161/
https://www.ncbi.nlm.nih.gov/pubmed/31130881
http://dx.doi.org/10.3389/fpsyt.2019.00294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510161/
https://www.ncbi.nlm.nih.gov/pubmed/31130881
http://dx.doi.org/10.3389/fpsyt.2019.00294

Ejemplares similares